{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:35:29Z","timestamp":1782207329791,"version":"3.54.5"},"reference-count":16,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2,1]]},"abstract":"<jats:p>Generalized lymphangiectasia is a rare congenital disorder characterized by dilated lymphatic vessels with a fatal prognosis, especially in cases with thoracic involvement. We describe the use of propranolol in the therapy of generalized lymphangiectasia in a preterm infant with hydrops fetalis. Propranolol was well tolerated and effective within the first months. It remains to be shown whether propranolol is a treatment option for infants with generalized lymphangiectasia.<\/jats:p>","DOI":"10.1542\/peds.2012-2087","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T02:09:09Z","timestamp":1390270149000},"page":"e439-e442","source":"Crossref","is-referenced-by-count":19,"title":["Treatment of Congenital Generalized Lymphangiectasia With Propranolol in a Preterm Infant"],"prefix":"10.1542","volume":"133","author":[{"given":"Christine","family":"Poralla","sequence":"first","affiliation":[{"name":"Departments of Neonatology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Specht","sequence":"additional","affiliation":[{"name":"Institute of Medical Microbiology, Immunology, and Parasitology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Born","sequence":"additional","affiliation":[{"name":"Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Paidopathology, University of Bonn, Bonn, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bartmann","sequence":"additional","affiliation":[{"name":"Departments of Neonatology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Departments of Neonatology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2014,2,1]]},"reference":[{"issue":"1","key":"2021120900293731300_B1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/ped.2010.0010","article-title":"Imaging of childhood interstitial lung disease.","volume":"23","author":"Guillerman","year":"2010","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"2","key":"2021120900293731300_B2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00043426-200402000-00018","article-title":"Thoracic lymphangiomatosis in a child.","volume":"26","author":"Alvarez","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"issue":"14","key":"2021120900293731300_B3","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJMc1013217","article-title":"Propranolol for intractable diffuse lymphangiomatosis.","volume":"364","author":"Ozeki","year":"2011","journal-title":"N Engl J Med"},{"issue":"24","key":"2021120900293731300_B4","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy.","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"2021120900293731300_B5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","article-title":"Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.","volume":"163","author":"Storch","year":"2010","journal-title":"Br J Dermatol"},{"key":"2021120900293731300_B6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev.cellbio.21.012704.132338","article-title":"The lymphatic vasculature: recent progress and paradigms.","volume":"21","author":"Oliver","year":"2005","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"5317","key":"2021120900293731300_B7","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.276.5317.1423","article-title":"Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.","volume":"276","author":"Jeltsch","year":"1997","journal-title":"Science"},{"issue":"11","key":"2021120900293731300_B8","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nm.2545","article-title":"The lymphatic vasculature in disease.","volume":"17","author":"Alitalo","year":"2011","journal-title":"Nat Med"},{"issue":"4","key":"2021120900293731300_B9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1515\/JPM.2004.067","article-title":"Impact of phototherapy on vasoactive mediators: NO and VEGF in the newborn.","volume":"32","author":"Turan","year":"2004","journal-title":"J Perinat Med"},{"key":"2021120900293731300_B10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1749-6632.2000.tb06227.x","article-title":"Angiogenic factors in the perinatal period: diversity in biological functions reflected in their serum concentrations soon after birth.","volume":"900","author":"Malamitsi-Puchner","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"2021120900293731300_B11","first-page":"641","article-title":"IGF-I, VEGF and bFGF as predictive factors for the onset of retinopathy of prematurity (ROP) [in Spanish].","volume":"81","author":"Villegas-Becerril","year":"2006","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"3","key":"2021120900293731300_B12","first-page":"199","article-title":"Comparison of serum levels of seven cytokines in premature newborns undergoing different ventilatory procedures: high frequency oscillatory ventilation or synchronized intermittent mandatory ventilation.","volume":"16","author":"Capoluongo","year":"2005","journal-title":"Eur Cytokine Netw"},{"issue":"2","key":"2021120900293731300_B13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cyto.2009.11.012","article-title":"Local serum levels of vascular endothelial growth factor in infantile hemangioma: intriguing mechanism of endothelial growth.","volume":"49","author":"Przewratil","year":"2010","journal-title":"Cytokine"},{"issue":"2","key":"2021120900293731300_B14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity.","volume":"153","author":"Sato","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2021120900293731300_B15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1620\/tjem.229.61","article-title":"Propranolol as an alternative treatment option for pediatric lymphatic malformation.","volume":"229","author":"Ozeki","year":"2013","journal-title":"Tohoku J Exp Med"},{"key":"2021120900293731300_B16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1471-2407-7-105","article-title":"Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas.","volume":"7","author":"Norgall","year":"2007","journal-title":"BMC Cancer"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/133\/2\/e439\/1059080\/peds_2012-2087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/133\/2\/e439\/1059080\/peds_2012-2087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T06:22:57Z","timestamp":1639030977000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/133\/2\/e439\/30867\/Treatment-of-Congenital-Generalized"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,1]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,1]]},"published-print":{"date-parts":[[2014,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2012-2087","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,1]]}}}